exacerb
asthma
copd
major
caus
morbid
mortal
healthcar
cost
last
decad
studi
use
new
molecular
diagnost
techniqu
establish
respiratori
virus
major
caus
exacerb
asthma
copd
preval
virus
detect
exacerb
rhinovirus
abbrevi
ena
epithelialderiv
neutrophil
attract
ifn
interferon
il
interleukin
leukotrien
nf
nuclear
factor
pcr
polymeras
chain
reaction
rant
regul
upon
activ
normal
tcell
express
secret
th
helper
tlr
tolllik
receptor
tnf
tumor
necrosi
factor
evid
virus
caus
exacerb
asthma
exacerb
associ
sever
factor
includ
allergen
exposur
air
pollut
uch
morbid
mortal
excess
healthcar
util
associ
asthma
copd
relat
episod
acut
deterior
health
term
exacerb
precis
definit
exacerb
remain
controversi
clinician
recogn
exacerb
increas
respiratori
symptom
usual
caus
patient
seek
medic
help
asthma
exacerb
associ
short
breath
cough
wheez
chest
tight
accompani
decreas
expiratori
airflow
manifest
reduct
peak
expiratori
flow
copd
exacerb
typic
associ
short
breath
cough
increas
sputum
volum
sputum
purul
nonspecif
symptom
fatigu
malais
chang
measur
airflow
gener
smaller
variabl
patient
asthma
acut
exacerb
result
excess
medic
use
emerg
depart
visit
hospit
even
death
main
driver
asthmarel
cost
account
almost
total
cost
copd
patient
experi
median
exacerb
per
year
frequenc
increas
increas
sever
diseas
exacerb
result
faster
declin
lung
function
patient
copd
direct
effect
progress
diseas
stress
major
caus
exacerb
respiratori
viru
infect
associ
cold
asthma
exacerb
long
recogn
earli
studi
yield
low
viru
detect
rate
approxim
studi
use
viru
detect
method
low
sensit
rhinovirus
coronavirus
account
major
cold
optimum
method
viru
detect
polymeras
chain
reaction
pcr
base
method
studi
use
pcr
shown
respiratori
virus
respons
much
higher
proport
asthma
exacerb
previous
suspect
studi
children
unit
kingdom
virus
detect
exacerb
common
virus
detect
rhinovirus
total
exacerb
viru
detect
respiratori
virus
also
detect
high
proport
sever
exacerb
requir
hospit
total
children
seen
emerg
depart
south
african
studi
test
posit
respiratori
viru
children
year
age
admit
hospit
wheez
ill
unit
state
virus
also
implic
pathogenesi
asthma
exacerb
adult
first
studi
use
pcr
detect
respiratori
virus
adult
report
respiratori
viru
exacerb
rhinovirus
subsequ
studi
patient
sever
exacerb
lead
present
emerg
depart
detect
viru
case
two
studi
australia
case
studi
unit
state
promin
role
rhinoviru
asthma
exacerb
highlight
canadian
studi
character
annual
septemb
epidem
asthma
hospit
occur
first
schoolag
children
follow
preschool
children
adult
respiratori
virus
act
synergist
factor
caus
asthma
exacerb
admiss
hospit
acut
asthma
exacerb
strongli
associ
combin
sensit
exposur
allergen
concurr
viral
infect
presenc
high
ambient
level
nitrogen
dioxid
prior
viral
infect
associ
lower
respiratori
tract
symptom
greater
fall
peak
expiratori
flow
exacerb
factor
associ
copd
exacerb
includ
chang
air
temperatur
concentr
air
pollut
exacerb
associ
symptom
respiratori
infect
histor
bacteria
consid
main
infect
caus
exact
role
remain
contenti
bacteria
found
approxim
half
copd
exacerb
also
found
patient
clinic
stabl
older
studi
detect
virus
exacerb
howev
case
asthma
patient
recent
studi
use
pcr
reveal
virus
promin
role
etiolog
exacerb
report
east
london
copd
cohort
respiratori
viru
identifi
patient
exacerb
treat
outpati
rhinovirus
account
virus
present
two
studi
copd
patient
sever
exacerb
requir
hospit
admiss
detect
respiratori
viru
patient
copd
patient
sever
exacerb
requir
intub
mechan
ventil
viral
infect
identifi
studi
focus
exclus
bacteri
viral
infect
recent
studi
carri
sampl
sputum
sampl
found
evid
coinfect
patient
exacerb
togeth
studi
suggest
mani
acut
exacerb
copd
associ
respiratori
viru
infect
despit
epidemiolog
evid
link
respiratori
viru
infect
exacerb
copd
asthma
cellular
molecular
mechan
virus
caus
exacerb
remain
undetermin
underli
patholog
asthma
copd
differ
markedli
therefor
key
question
whether
mechan
virusinduc
exacerb
two
diseas
similar
differ
answer
question
academ
interest
current
treatment
exacerb
inadequ
new
treatment
urgent
need
much
knowledg
regard
mechan
virusinduc
asthma
exacerb
deriv
studi
use
experiment
rhinoviru
infect
asthmat
volunt
model
exacerb
view
data
avail
rhinoviru
model
role
commonli
identifi
viru
patient
asthma
copd
review
focu
mainli
mechan
rhinovirusinduc
exacerb
key
issu
regard
virusinduc
exacerb
airway
diseas
whether
upper
respiratori
tract
virus
rhinovirus
also
infect
lower
airway
prevail
view
mani
year
could
base
evid
optim
temperatur
growth
rhinovirus
howev
papadopoulo
et
al
demonstr
rhinoviru
replic
lower
airway
epithelium
use
situ
hybrid
exclud
sampl
contamin
upper
airway
therefor
viral
infect
lower
airway
like
occur
contribut
virusinduc
exacerb
asthma
copd
extent
epitheli
cell
destruct
observ
airway
vari
accord
viru
type
influenza
typic
caus
extens
epitheli
necrosi
wherea
rhinoviru
caus
patchi
damag
respiratori
epithelium
import
regulatori
role
contribut
immun
respons
follow
viru
infect
product
inflammatori
mediat
cytokin
chemokin
diseas
syndrom
follow
respiratori
viru
infect
consequ
direct
harm
effect
viru
immunopatholog
result
host
immun
respons
led
concept
rhinoviru
infect
least
part
immunemedi
diseas
proinflammatori
cytokin
chemokin
inflammatori
cell
product
produc
patholog
perhap
direct
cytotox
effect
viru
viral
infect
asthmat
patient
induc
lower
respiratori
tract
symptom
fall
lung
function
nonasthmat
patient
molecular
basi
greater
sensit
asthmat
patient
viral
infect
remain
obscur
vitro
infect
airway
epitheli
cell
rhinoviru
induc
secret
host
inflammatori
mediat
also
occur
vivo
experiment
natur
acquir
viral
infect
neutrophil
chemokin
interleukin
il
proinflammatori
cytokin
detect
nasal
sampl
viru
infect
asthmat
patient
lower
respiratori
tract
increas
chemokin
regul
activ
normal
tcell
express
secret
rant
document
sputum
asthmat
patient
experiment
rhinoviru
infect
detect
sputum
children
natur
occur
exacerb
wellrecogn
viral
infect
induc
proinflammatori
mediat
unclear
whether
inflammatori
respons
viral
infect
differ
quantit
qualit
asthmat
patient
one
experiment
rhinoviru
infect
studi
report
increas
level
nasal
lavag
sampl
asthmat
patient
control
subject
howev
anoth
studi
report
differ
granulocytemonocytecoloni
stimul
factor
level
either
nasal
lavag
sputum
sampl
recent
studi
patient
natur
occur
virusassoci
asthma
exacerb
found
increas
level
messeng
rna
sputum
asthmat
patient
compar
virusinfect
healthi
subject
differ
level
rant
two
group
conflict
result
highlight
need
studi
evalu
inflammatori
profil
prefer
lower
airway
wellcharacter
patient
exacerb
studi
control
subject
nonasthmat
patient
help
ascertain
whether
inflammatori
respons
asthmat
patient
differ
healthi
subject
product
chemokin
epitheli
cell
respons
viral
infect
lead
influx
leukocyt
airway
cell
essenti
part
innat
adapt
immun
respons
also
result
airway
patholog
releas
inflammatori
cell
product
neutrophil
elastas
neutrophil
major
basic
protein
eosinophil
cation
protein
eosinophil
reactiv
oxygen
speci
caus
tissu
damag
stabl
patient
asthma
eosinophil
cell
identifi
key
cellular
compon
asthma
phenotyp
cellular
respons
exacerb
heterogen
sever
asthma
exacerb
children
associ
increas
inflammatori
cell
number
presenc
neutrophil
eosinophil
marker
sputum
sampl
increas
level
sputum
neutrophil
report
virusassoci
exacerb
adult
wherea
exacerb
viru
detect
higher
proport
eosinophil
experiment
rhinoviru
infect
studi
report
increas
number
neutrophil
bal
fluid
sampl
sputum
sampl
studi
compar
inflammatori
cellular
respons
viral
infect
asthmat
patient
healthi
subject
increas
number
lymphocyt
eosinophil
bronchial
biopsi
specimen
present
experiment
rhinoviru
infect
asthmat
patient
healthi
subject
howev
week
postinfect
eosinophilia
persist
asthmat
patient
studi
greater
total
sputum
inflammatori
cell
count
neutrophil
count
similar
differenti
count
asthmat
patient
therefor
would
seem
virusinduc
exacerb
least
partial
driven
neutrophil
inflamm
may
account
therapi
inhal
corticosteroid
effect
suppress
eosinophil
airway
inflamm
stabl
patient
asthma
less
success
prevent
exacerb
new
treatment
may
need
target
neutrophil
neutrophil
chemokin
virusinduc
exacerb
prevent
amelior
adapt
immun
respons
asthma
patient
associ
thelper
th
type
cytokin
profil
ie
wherea
adequ
antivir
immun
respons
requir
cytokin
interferon
ifn
immun
respons
demonstr
mutual
inhibit
therefor
within
airway
preexist
microenviron
may
inhibit
immun
respons
clinic
evid
imbal
immun
respons
influenc
outcom
viral
infect
peripher
blood
mononuclear
cell
asthmat
subject
expos
rhinoviru
produc
significantli
lower
level
lower
ratio
nonasthmat
patient
gern
et
al
show
invers
relationship
ratio
sputum
sampl
peak
cold
symptom
time
viru
clearanc
sputum
sampl
asthmat
patient
infect
rhinoviru
suggest
stronger
immun
respons
associ
less
sever
cold
faster
viral
clearanc
also
evid
weak
respons
associ
sever
diseas
infect
anoth
respiratori
virusrespiratori
syncyti
viru
suggest
may
anoth
mechan
viru
infect
exacerb
preexist
lung
diseas
immunolog
research
asthma
focus
role
adapt
immun
respons
diseas
pathogenesi
evid
emerg
suggest
innat
immun
may
impair
asthmat
patient
wark
et
al
shown
bronchial
epitheli
cell
obtain
asthmat
patient
support
markedli
increas
rhinoviru
replic
compar
cell
nonasthmat
patient
accompani
reduc
apoptosi
epitheli
cell
asthmat
patient
impair
product
antivir
cytokin
impair
product
cell
apoptosi
result
greater
viru
replic
eventu
lead
cytotox
cell
death
releas
inflammatori
mediat
larg
number
intact
viral
particl
administr
restor
viru
protect
observ
epitheli
cell
normal
airway
confirm
vivo
interest
see
whether
novel
observ
translat
new
therapi
aim
augment
replac
defici
product
asthma
patient
key
differ
innat
acquir
antivir
respons
asthmat
patient
nonasthmat
patient
summar
figur
compon
innat
immun
respons
may
influenc
host
respons
viral
infect
tolllik
receptor
tlr
defensin
tlr
induc
antivir
respons
type
ifn
well
inflammatori
cytokin
releas
recruit
cell
requir
host
defens
respons
microbi
product
defensin
antimicrobi
peptid
multipl
effect
innat
acquir
immun
respons
one
tlr
activ
doublestrand
rna
form
viral
replic
rhinoviru
induc
express
defensin
human
respiratori
epitheli
cell
addit
upregul
allerg
airway
inflamm
studi
requir
explor
possibl
interact
viral
infect
allerg
inflamm
tlr
express
may
influenc
host
respons
respiratori
viru
infect
copd
associ
pulmonari
system
inflammatori
respons
studi
airway
inflamm
stabl
patient
copd
shown
diseas
character
pulmonari
infiltr
macrophag
neutrophil
lymphocyt
togeth
increas
express
cytokin
chemokin
adhes
molecul
much
less
work
carri
studi
airway
inflamm
exacerb
result
often
conflict
compar
result
differ
studi
often
hamper
differ
inclus
criteria
eg
chronic
bronchiti
vs
copd
differ
definit
copd
differ
method
airway
sampl
unlik
cytokin
eosinophil
chemokin
characterist
asthma
copd
associ
proinflammatori
cytokin
neutrophil
chemokin
tumor
necrosi
factor
tnf
growthrel
leukotrien
airway
inflamm
amplifi
exacerb
level
inflammatori
mediat
increas
compar
stabl
state
increas
level
epithelialderiv
neutrophil
attract
ena
rant
report
exacerb
believ
key
neutrophil
chemokin
copd
studi
report
increas
level
exacerb
other
studi
use
bronchial
biopsi
specimen
patient
sever
exacerb
copd
report
posit
correl
neutrophil
cell
posit
domin
cxc
chemoattract
exacerb
associ
activ
transcript
factor
nuclear
factor
nf
b
macrophag
induc
sputum
sampl
activ
nfb
rhinoviru
demonstr
vitro
may
one
mechan
wherebi
respiratori
virus
upregul
proinflammatori
mediat
airway
although
known
whether
rhinovirus
infect
macrophag
chemotact
effect
neutrophil
ie
lymphocyt
monocyt
ie
rant
upregul
adhes
molecul
ie
mediat
may
central
compon
increas
inflamm
characterist
exacerb
fig
avail
data
regard
role
exacerb
etiolog
airway
inflamm
determin
whether
differ
etiolog
associ
specif
profil
inflammatori
mediat
number
studi
report
bacteri
exacerb
associ
higher
level
sputum
bacteri
pathogen
isol
virusassoci
exacerb
associ
higher
level
sputum
one
studi
wherea
anoth
studi
rhinoviru
associ
signific
chang
level
sputum
inflammatori
marker
other
report
increas
level
airway
inflammatori
marker
occur
independ
demonstr
viral
bacteri
infect
releas
cytokin
airway
epitheli
cell
viral
infect
lead
influx
inflammatori
cell
inflammatori
cell
releas
product
neutrophil
elastas
reactiv
oxygen
speci
caus
tissu
damag
stimul
mucu
product
stimul
cytokin
product
howev
studi
cellular
inflammatori
respons
copd
exacerb
consi
normal
airway
epitheli
cell
viral
infect
induc
product
turn
induc
apoptosi
virusinfect
cell
limit
viru
replic
follow
adapt
immun
respons
character
cell
produc
lead
strong
antivir
respons
rapid
clearanc
viru
minim
inflamm
asthmat
patient
innat
adapt
antivir
immun
may
impair
result
cell
necrosi
releas
inflammatori
mediat
viru
increas
viral
load
level
inflammatori
mediat
releas
necrot
cell
result
uncontrol
airway
inflamm
exacerb
increas
neutrophil
eosinophil
lymphocyt
count
studi
copd
patient
intub
sever
exacerb
increas
number
neutrophil
seen
bronchial
biopsi
specimen
compar
stabl
patient
copd
cell
type
report
one
studi
attempt
correl
pattern
airway
inflamm
exacerb
etiolog
studi
level
sputum
neutrophil
elev
exacerb
regardless
etiolog
level
eosinophil
increas
patient
viral
infect
variabl
result
highlight
need
studi
care
select
popul
coupl
determin
exacerb
etiolog
therefor
although
well
establish
copd
exacerb
associ
increas
airway
inflamm
mark
variabl
natur
inflammatori
respons
relationship
airway
inflamm
etiolog
establish
identif
valid
biomark
exacerb
allow
object
diagnosi
exacerb
determin
sever
addit
marker
distinguish
viral
bacteri
infect
potenti
reduc
overus
antibiot
target
use
antivir
agent
becom
avail
despit
advanc
made
treatment
asthma
copd
acut
exacerb
remain
major
caus
morbid
mortal
recent
year
seen
epidemiolog
evid
link
virus
exacerb
get
ever
stronger
stage
set
progress
identifi
import
mechan
virusinduc
asthma
exacerb
viral
infect
associ
airway
inflamm
studi
cellular
molecular
respons
infect
shown
clearcut
qualit
quantit
differ
asthmat
patient
nonasthmat
subject
studi
compar
virusinduc
inflamm
copd
patient
healthi
control
subject
recent
evid
impair
innat
immun
chemokin
attract
inflammatori
cell
releas
toxic
product
stimul
mucu
product
lead
tissu
damag
possibl
longterm
loss
lung
function
mediat
direct
effect
caus
bronchoconstrict
vasoconstrict
result
airflow
obstruct
impair
ga
exchang
mmp
matrix
metalloproteinas
ro
reactiv
oxygen
speci
vq
ventilationperfus
asthmat
patient
suggest
may
key
mechan
pathogenesi
virusinduc
asthma
exacerb
work
need
identifi
whether
similar
mechan
involv
copd
exacerb
identifi
key
inflammatori
mediat
involv
exacerb
well
host
defens
mechan
provid
protect
hold
promis
develop
new
therapeut
agent
reduc
burden
diseas
associ
asthma
copd
exacerb
